NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Arcus Biosciences (RCUS) Technical (Analysis) Reports Arcus Biosciences ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Arcus Biosciences (RCUS)

Technical Analysis Report for NYSE stock RCUS Arcus Biosciences. Dated: 27 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange

If you are looking for Tomorrow's Movement Predictions for NYSE stock RCUS Arcus Biosciences then click here. or read Experts views on Arcus Biosciences or Forecast & share price targets of Arcus Biosciences

Arcus Biosciences Opened at 28.67 and Closed at: 27.84, which is -2.08% of previous session's close. It moved within a range of 27.83 and 29.63
The session was a Bearish session with an average volume of 1268800, which is 3.02% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
• Even though the stock has fallen, but its long term trend is positive and in an uptrend.

A Dead cross was found 8 days back on short term averages

Support for tomorrow is 26.94 and resistance for tomorrow is 28.74
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 27.24, 26.63 resistance for tomorrow's hourly charts is 29.04, 30.23

10 Day SMA for Arcus Biosciences (RCUS) is 28.41 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Arcus Biosciences (RCUS) is 29 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Arcus Biosciences (RCUS) is 26.59 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 25.05 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Arcus Biosciences is 23.14 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Arcus Biosciences is at 29 and 200 DMA is at 23.14, while 50 DMA and 100 DMA are at 26.59 and 25.05 respectively

Arcus Biosciences (RCUS) moving average of 20 SMA is at 29 and 20 EMA is at 28.44

Arcus Biosciences (RCUS) moving average of 50 SMA is at 26.59 and 50 EMA is at 27.15

Arcus Biosciences (RCUS) moving average of 100 SMA is at 25.05 and 100 EMA is at 25.45

Arcus Biosciences (RCUS) moving average of 200 SMA is at 23.14 and 200 EMA is at 22.66

Unitedhealth Group has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Unitedhealth Group, about 10.21% more returns!

Universal Health has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Universal Health, about 16.79% more returns!

Teleflex Incorporated has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Teleflex Incorporated, about 13.08% more returns!

Steris Plc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Steris Plc, about 13.42% more returns!

Prestige Consumer has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Prestige Consumer, about 16.32% more returns!

Mednax Inc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Mednax Inc, about 12.9% more returns!

Eli Lilly has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Eli Lilly, about 9.58% more returns!

Haemonetics Corporation has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 16.25% more returns!

Globus Medical has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Globus Medical, about 8.74% more returns!

Glaukos Corporation has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Glaukos Corporation, about 18.39% more returns!

Edwards Lifesciences has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 1.5% more returns!

Arcus Biosciences has performed better than Community Health in short term. Holding Arcus Biosciences could be a better choice for now!

Cvs Health has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Cvs Health, about 13.2% more returns!

Cigna Corporation has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Cigna Corporation, about 15.26% more returns!

Brookdale Senior has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Brookdale Senior, about 5.78% more returns!

Arcus Biosciences has performed better than Astrazeneca Plc in short term. Holding Arcus Biosciences could be a better choice for now!

Abbvie Inc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Abbvie Inc, about 11.87% more returns!

Arcus Biosciences Technical analysis of indicators

Price action analysis of Arcus Biosciences (RCUS) based on a short term time period is neutral. A longer time frame might give a better analysis.

ADX buy sell signal for Arcus Biosciences stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a SELL signal for Arcus Biosciences in short term but the sell signal is initial and weak.

Arcus Biosciences Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

CCI has generated a SELL signal for Arcus Biosciences in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Arcus Biosciences is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 28.51 and Arcus Biosciences RCUS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Arcus Biosciences RCUS stock. Volume based technical analysis of Arcus Biosciences RCUS stock is negative.

Arcus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NYSE stock RCUS Arcus Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And RCUS Experts View which covers a lot of information including buying and selling signals

RCUS future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arcus Biosciences or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet